News & Media :: Vedanta Biosciences, Inc.

Oct 4, 2018

Vedanta Biosciences Announces Successful Phase 1a/1b Data Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead, Rationally Defined Bacterial Consortium Product Candidate, VE303

Recent News

Sep 6, 2018

Vedanta IP estate and scientific cofounder ranked among the top 20 most impactful in biotech in 2017

Sep 5, 2018

Vedanta Biosciences Appoints Susan Dillon, PhD, to Board of Directors

Jul 10, 2018

Vedanta Biosciences Receives Award from the Crohn’s & Colitis Foundation to Advance a Microbiome-Derived Therapeutic Program for Interception and Treatment of Inflammatory Bowel Disease

Jun 18, 2018

Startup aims to make allies of human gut’s microbes

View All News View All Press Releases